Pharmaceutical
companies don't have nearly the access to doctors that they once enjoyed.
ZS, a
global sales and marketing firm, analyzed call reports from 70 percent of pharmaceutical
sales reps and found that for the first time since it began conducting such
reports, more than half of physicians were classified as restricted to a
certain extent from engaging with pharma reps.
The decline
in access has been dramatic over the past five years. While nearly 80 percent
of doctors were considered accessible in the first quarter of 2009, only 47
percent are unrestricted today.